doxorubicin

The drug is used to treat metastatic breast cancer, progressive ovarian cancer, multiple myeloma (in combination with bortezomib), as well as AIDS-associated Kaposi's sarcoma.

Form: concentrate for infusion solution, liposomal

ATC: L01DB01

Manufacturer: NATKO PHARMA LIMITED

The drug is used to treat a wide range of neoplastic diseases, including acute leukemia, lymphoma, solid tumors in adults (e.g., breast and lung cancer), as well as malignant neoplasms in children.

Form: concentrate for infusion solution

ATC: L01DB01

Manufacturer: EBEWE Pharma Ges.m.b.H. Nfg. KG (batch release)

The drug is used for the systemic treatment of various types of malignant neoplasms, including breast cancer, soft tissue sarcoma, Ewing sarcoma, small cell lung cancer, lymphomas (Hodgkin's disease and non-Hodgkin's lymphomas), leukemias, thyroid cancer, bladder cancer, ovarian cancer, Wilms tumor, and neuroblastoma.

Form: concentrate for infusion solution

ATC: L01DB01

Manufacturer: Intas Pharmaceuticals Limited (manufacturing, quality control, primary and secondary packaging)

The drug is used to treat a wide range of neoplastic diseases, including acute leukemia, lymphoma, soft tissue sarcoma, and osteosarcoma, as well as malignant neoplasms in children and solid tumors in adults (e.g., breast and lung cancer).

Form: solution for injection

ATC: L01DB01

Manufacturer: Thymoorganon Pharmazie GmbH

The drug is used to treat a wide range of oncological diseases, including acute leukemia, lymphoma, soft tissue sarcoma, and osteosarcoma, as well as tumors in children and solid tumors in adults (e.g., breast and lung cancer).

Form: solution for injection

ATC: L01DB01

Manufacturer: Venus Remedies Limited

The drug is used to treat a wide range of oncological diseases, including acute leukemia, lymphoma, malignant tumors in children, as well as solid tumors in adults (e.g., breast and lung cancer).

Form: concentrate for infusion solution

ATC: L01DB01

Manufacturer: Actavis Italia S.p.A.